FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Front Vet Sci / Stem Cells in Veterinary Medicine-Current State and Treatmen...
Frontiers in veterinary science2020; 7; 278; doi: 10.3389/fvets.2020.00278

Stem Cells in Veterinary Medicine-Current State and Treatment Options.

Abstract: Regenerative medicine is a branch of medicine that develops methods to grow, repair, or replace damaged or diseased cells, organs or tissues. It has gained significant momentum in recent years. Stem cells are undifferentiated cells with the capability to self-renew and differentiate into tissue cells with specialized functions. Stem cell therapies are therefore used to overcome the body's inability to regenerate damaged tissues and metabolic processes after acute or chronic insult. The concept of stem cell therapy was first introduced in 1991 by Caplan, who proposed that massive differentiation of cells into the desired tissue could be achieved by isolation, cultivation, and expansion of stem cells in in vitro conditions. Among different stem cell types, mesenchymal stem cells (MSC) currently seem to be the most suitable for therapeutic purposes, based on their simple isolation and culturing techniques, and lack of ethical issues regarding their usage. Because of their remarkable immunomodulatory abilities, MSCs are increasingly gaining recognition in veterinary medicine. Developments are primarily driven by the limitations of current treatment options for various medical problems in different animal species. MSCs represent a possible therapeutic option for many animal diseases, such as orthopedic, orodental and digestive tract diseases, liver, renal, cardiac, respiratory, neuromuscular, dermal, olfactory, and reproductive system diseases. Although we are progressively gaining an understanding of MSC behavior and their mechanisms of action, some of the issues considering their use for therapy are yet to be resolved. The aim of this review is first to summarize the current knowledge and stress out major issues in stem cell based therapies in veterinary medicine and, secondly, to present results of clinical usage of stem cells in veterinary patients.
Copyright © 2020 Voga, Adamic, Vengust and Majdic.
Get Full Text
Publication Date: 2020-05-29 PubMed ID: 32656249PubMed Central: PMC7326035DOI: 10.3389/fvets.2020.00278Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article discusses the role of stem cells in veterinary medicine and how regenerative medicine, specifically through the use of mesenchymal stem cells (MSCs), may offer promising treatment options for various animal diseases.

Regenerative Medicine and Stem Cells

  • Regenerative medicine is a field that aims to replace or repair damaged cells, tissues, or organs. It is a rapidly evolving area and has gained significant momentum in recent years.
  • The core of this approach lies in stem cells – undifferentiated cells capable of self-renewal and differentiation (turning into different types of cells). Stem cells therapy is used to aid the body’s regeneration of damaged tissues, overcoming its inability to do so efficiently.
  • First proposed by Caplan in 1991, the concept of stem cell therapy involves isolating, cultivating, and expanding stem cells to aim for a massive differentiation of these cells into the required tissue type.

Role of Mesenchymal Stem Cells (MSCs)

  • Of different stem cell types, MSCs are favored for therapeutic purposes due to their simple isolation and culturing techniques, and the absence of ethical issues related to their usage.
  • MSCs have strong immunomodulatory abilities, making them increasingly popular in veterinary medicine where they could be a potential solution for various conditions affecting animals. These include diseases impacting the orthopedic, orodental and digestive tract, liver, kidney, heart, respiratory system, neuromuscular functions, skin, olfaction (sense of smell), and reproductive system.

Challenges and Future Directions

  • While our understanding of MSCs, their behaviours and how they perform their actions is growing, many issues regarding their therapeutic use remain unresolved.
  • The goal of this review was to summarize the current knowledge on stem cell therapies in veterinary medicine, highlight major issues, and discuss the clinical application of stem cells in treating animal patients.

Cite This Article

APA
Voga M, Adamic N, Vengust M, Majdic G. (2020). Stem Cells in Veterinary Medicine-Current State and Treatment Options. Front Vet Sci, 7, 278. https://doi.org/10.3389/fvets.2020.00278

Publication

Frontiers in veterinary science
ISSN: 2297-1769
NlmUniqueID: 101666658
Country: Switzerland
Language: English
Volume: 7
Pages: 278

Researcher Affiliations

Voga, Metka
  • Faculty of Veterinary Medicine, University of Ljubljana, Ljubljana, Slovenia.
Adamic, Neza
  • Faculty of Veterinary Medicine, University of Ljubljana, Ljubljana, Slovenia.
Vengust, Modest
  • Faculty of Veterinary Medicine, University of Ljubljana, Ljubljana, Slovenia.
Majdic, Gregor
  • University of Ljubljana, Ljubljana, Slovenia.

References

This article includes 270 references
  1. Morrison SJ, Wandycz AM, Hemmati HD, Wright DE, Weissman IL. Identification of a lineage of multipotent hematopoietic progenitors. Development (1997) 124:1929–39.
    pubmed: 9169840
  2. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature (1981) 292:154–6.
    doi: 10.1038/292154a0pubmed: 7242681google scholar: lookup
  3. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 126:663–76.
    doi: 10.1016/j.cell.2006.07.024pubmed: 16904174google scholar: lookup
  4. Wagers AJ, Weissman IL. Plasticity of adult stem cells. Cell (2004) 116:639–48.
    doi: 10.1016/S0092-8674(04)00208-9pubmed: 15006347google scholar: lookup
  5. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA (1981) 78:7634–8.
    doi: 10.1073/pnas.78.12.7634pmc: PMC349323pubmed: 6950406google scholar: lookup
  6. Thomson JA, Marshall VS. Primate embryonic stem cells. Curr Top Dev Biol (1998) 38:133–65.
    doi: 10.1016/S0070-2153(08)60246-Xpubmed: 9399078google scholar: lookup
  7. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS. Embryonic stem cell lines derived from human blastocysts. Science (1998) 282:1145–7.
    doi: 10.1126/science.282.5391.1145pubmed: 9804556google scholar: lookup
  8. Caplan AI. Mesenchymal stem cells. J Orthop Res (1991) 9:641–50.
    doi: 10.1002/jor.1100090504pubmed: 1870029google scholar: lookup
  9. Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation (1968) 6:230–47.
    doi: 10.1097/00007890-196803000-00009pubmed: 5654088google scholar: lookup
  10. Dennis JE, Merriam A, Awadallah A, Yoo JU, Johnstone B, Caplan AI. A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse. J Bone Miner Res (1999) 14:700–9.
    doi: 10.1359/jbmr.1999.14.5.700pubmed: 10320518google scholar: lookup
  11. Miyahara Y, Nagaya N, Kataoka M, Yanagawa B, Tanaka K, Hao H. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med (2006) 12:459–65.
    doi: 10.1038/nm1391pubmed: 16582917google scholar: lookup
  12. Quinn C, Flake AW. In vivo differentiation potential of mesenchymal stem cells: prenatal and postnatal model systems. Transfus Med Hemother (2008) 35:239–47.
    doi: 10.1159/000129129pmc: PMC3083291pubmed: 21547121google scholar: lookup
  13. Niess H, Thomas MN, Schiergens TS, Kleespies A, Jauch KW, Bruns C. Genetic engineering of mesenchymal stromal cells for cancer therapy: turning partners in crime into Trojan horses. Innov Surg Sci (2016) 1:19–32.
    doi: 10.1515/iss-2016-0005pmc: PMC6753982pubmed: 31579715google scholar: lookup
  14. Caplan AI. Mesenchymal stem cells: time to change the name! stem cells. Transl Med (2017) 6:1445–51.
    doi: 10.1002/sctm.17-0051pmc: PMC5689741pubmed: 28452204google scholar: lookup
  15. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy (2006) 8:315–7.
    doi: 10.1080/14653240600855905pubmed: 16923606google scholar: lookup
  16. Sasaki A, Mizuno M, Ozeki N, Katano H, Otabe K, Tsuji K. Canine mesenchymal stem cells from synovium have a higher chondrogenic potential than those from infrapatellar fat pad, adipose tissue, and bone marrow. PLoS ONE (2018) 13:e0202922.
    doi: 10.1371/journal.pone.0202922pmc: PMC6107231pubmed: 30138399google scholar: lookup
  17. Bearden RN, Huggins SS, Cummings KJ, Smith R, Gregory CA, Saunders WB. In-vitro characterization of canine multipotent stromal cells isolated from synovium, bone marrow, and adipose tissue: a donor-matched comparative study. Stem Cell Res Ther (2017) 8:218.
    doi: 10.1186/s13287-017-0639-6pmc: PMC5627404pubmed: 28974260google scholar: lookup
  18. Zhang S, Zhao C, Liu S, Wang Y, Zhao Y, Guan W. Characteristics and multilineage differentiation of bone marrow mesenchymal stem cells derived from the Tibetan mastiff. Mol Med Rep (2018) 18:2097–109.
    doi: 10.3892/mmr.2018.9172pmc: PMC6072167pubmed: 29916546google scholar: lookup
  19. Kang BJ, Ryu HH, Park SS, Koyama Y, Kikuchi M, Woo HM. Comparing the osteogenic potential of canine mesenchymal stem cells derived from adipose tissues, bone marrow, umbilical cord blood, and Wharton's Jelly for treating bone defects. J Vet Sci (2012) 13:299–310.
    doi: 10.4142/jvs.2012.13.3.299pmc: PMC3467406pubmed: 23000587google scholar: lookup
  20. Radtke CL, Nino-Fong R, Esparza, Gonzalez BP, Stryhn H, McD￮ LA. Characterization and osteogenic potential of equine muscle tissue- and periosteal tissue-derived mesenchymal stem cells in comparison with bone marrow- and adipose tissue-derived mesenchymal stem cells. Am J Vet Res (2013) 74:790–800.
    doi: 10.2460/ajvr.74.5.790pubmed: 23627394google scholar: lookup
  21. Arevalo-Turrubiarte M, Olmeo C, Accornero P, Baratta M, Martignani E. Analysis of mesenchymal cells (MSCs) from bone marrow, synovial fluid and mesenteric, neck and tail adipose tissue sources from equines. Stem Cell Res (2019) 37:101442.
    doi: 10.1016/j.scr.2019.101442pubmed: 31026685google scholar: lookup
  22. Martin DR, Cox NR, Hathcock TL, Niemeyer GP, Baker HJ. Isolation and characterization of multipotential mesenchymal stem cells from feline bone marrow. Exp Hematol (2002) 30:879–86.
    doi: 10.1016/S0301-472X(02)00864-0pubmed: 12160839google scholar: lookup
  23. Webb TL, Quimby JM, Dow SW. In vitro comparison of feline bone marrow-derived and adipose tissue-derived mesenchymal stem cells. J Feline Med Surg (2012) 14:165–8.
    doi: 10.1177/1098612X11429224pmc: PMC10822480pubmed: 22314096google scholar: lookup
  24. Lee BY, Li Q, Song WJ, Chae HK, Kweon K, Ahn JO. Altered properties of feline adipose-derived mesenchymal stem cells during continuous in vitro cultivation. J Vet Med Sci (2018) 80:930–8.
    doi: 10.1292/jvms.17-0563pmc: PMC6021870pubmed: 29669964google scholar: lookup
  25. Krawetz RJ, Wu YE, Martin L, Rattner JB, Matyas JR, Hart DA. Synovial fluid progenitors expressing CD90+ from normal but not osteoarthritic joints undergo chondrogenic differentiation without micro-mass culture. PLoS ONE (2012) 7:e43616.
    doi: 10.1371/journal.pone.0043616pmc: PMC3430696pubmed: 22952721google scholar: lookup
  26. Prado AA, Favaron PO, da Silva LC, Baccarin RY, Miglino MA, Maria DA. Characterization of mesenchymal stem cells derived from the equine synovial fluid and membrane. BMC Vet Res (2015) 11:281.
    doi: 10.1186/s12917-015-0531-5pmc: PMC4640348pubmed: 26555093google scholar: lookup
  27. Zhang BY, Wang BY, Li SC, Luo DZ, Zhan X, Chen SF. Evaluation of the curative effect of umbilical cord mesenchymal stem cell therapy for knee arthritis in dogs using imaging technology. Stem Cells Int (2018) 2018:1983025.
    doi: 10.1155/2018/1983025pmc: PMC5976915pubmed: 29861739google scholar: lookup
  28. Denys M, Leon A, Robert C, Saulnier N, Josson-Schramme A, Legrand L. Biosafety evaluation of equine umbilical cord-derived mesenchymal stromal cells (UC-MSCs) by systematic pathogen screening in peripheral maternal blood and paired UC-MSCs. Biopreserv Biobank (2020) 18:73–81.
    doi: 10.1089/bio.2019.0071pubmed: 31904273google scholar: lookup
  29. Carrade DD, Affolter VK, Outerbridge CA, Watson JL, Galuppo LD, Buerchler S. Intradermal injections of equine allogeneic umbilical cord-derived mesenchymal stem cells are well tolerated and do not elicit immediate or delayed hypersensitivity reactions. Cytotherapy (2011) 13:1180–92.
    doi: 10.3109/14653249.2011.602338pubmed: 21899391google scholar: lookup
  30. Koch TG, Heerkens T, Thomsen PD, Betts DH. Isolation of mesenchymal stem cells from equine umbilical cord blood. BMC Biotechnol (2007) 7:26.
    doi: 10.1186/1472-6750-7-26pmc: PMC1904213pubmed: 17537254google scholar: lookup
  31. Carrade DD, Owens SD, Galuppo LD, Vidal MA, Ferraro GL, Librach F. Clinicopathologic findings following intra-articular injection of autologous and allogeneic placentally derived equine mesenchymal stem cells in horses. Cytotherapy (2011) 13:419–30.
    doi: 10.3109/14653249.2010.536213pubmed: 21105841google scholar: lookup
  32. Kisiel AH, McD￮ LA, Masaoud E, Bailey TR, Esparza Gonzalez BP, Nino-Fong R. Isolation, characterization, and in vitro proliferation of canine mesenchymal stem cells derived from bone marrow, adipose tissue, muscle, and periosteum. Am J Vet Res (2012) 73:1305–17.
    doi: 10.2460/ajvr.73.8.1305pubmed: 22849692google scholar: lookup
  33. Mensing N, Gasse H, Hambruch N, Haeger JD, Pfarrer C, Staszyk C. Isolation and characterization of multipotent mesenchymal stromal cells from the gingiva and the periodontal ligament of the horse. BMC Vet Res (2011) 7:42.
    doi: 10.1186/1746-6148-7-42pmc: PMC3161857pubmed: 21810270google scholar: lookup
  34. Sato K, Yamawaki-Ogata A, Kanemoto I, Usui A, Narita Y. Isolation and characterisation of peripheral blood-derived feline mesenchymal stem cells. Vet J (2016) 216:183–8.
    doi: 10.1016/j.tvjl.2016.08.009pubmed: 27687950google scholar: lookup
  35. Longhini ALF, Salazar TE, Vieira C, Trinh T, Duan Y, Pay LM. Peripheral blood-derived mesenchymal stem cells demonstrate immunomodulatory potential for therapeutic use in horses. PLoS ONE (2019) 14:e0212642.
    doi: 10.1371/journal.pone.0212642pmc: PMC6417789pubmed: 30870461google scholar: lookup
  36. Spaas JH, Broeckx S, Van de Walle GR, Polettini M. The effects of equine peripheral blood stem cells on cutaneous wound healing: a clinical evaluation in four horses. Clin Exp Dermatol (2013) 38:280–4.
    doi: 10.1111/ced.12068pmc: PMC3627309pubmed: 23517358google scholar: lookup
  37. Marfe G, Massaro-Giordano M, Ranalli M, Cozzoli E, Di Stefano C, Malafoglia V. Blood derived stem cells: an ameliorative therapy in veterinary ophthalmology. J Cell Physiol (2012) 227:1250–6.
    doi: 10.1002/jcp.22953pubmed: 21792938google scholar: lookup
  38. Rink BE, Amilon KR, Esteves CL, French HM, Watson E, Aurich C. Isolation and characterization of equine endometrial mesenchymal stromal cells. Stem Cell Res Ther (2017) 8:166.
    doi: 10.1186/s13287-017-0616-0pmc: PMC5506676pubmed: 28701175google scholar: lookup
  39. da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci (2006) 119:2204–13.
    doi: 10.1242/jcs.02932pubmed: 16684817google scholar: lookup
  40. Russell KA, Chow NH, Dukoff D, Gibson TW, LaMarre J, Betts DH. Characterization and immunomodulatory effects of canine adipose tissue- and bone marrow-derived mesenchymal stromal cells. PLoS ONE (2016) 11:e0167442.
    doi: 10.1371/journal.pone.0167442pmc: PMC5131977pubmed: 27907211google scholar: lookup
  41. Villatoro AJ, Alcoholado C, Martin-Astorga MC, Fernandez V, Cifuentes M, Becerra J. Comparative analysis and characterization of soluble factors and exosomes from cultured adipose tissue and bone marrow mesenchymal stem cells in canine species. Vet Immunol Immunopathol (2019) 208:6–15.
    doi: 10.1016/j.vetimm.2018.12.003pubmed: 30712794google scholar: lookup
  42. Vidal MA, Robinson SO, Lopez MJ, Paulsen DB, Borkhsenious O, Johnson JR. Comparison of chondrogenic potential in equine mesenchymal stromal cells derived from adipose tissue and bone marrow. Vet Surg (2008) 37:713–24.
    doi: 10.1111/j.1532-950X.2008.00462.xpmc: PMC2746327pubmed: 19121166google scholar: lookup
  43. Fideles SOM, Ortiz AC, Assis AF, Duarte MJ, Oliveira FS, Passos GA. Effect of cell source and osteoblast differentiation on gene expression profiles of mesenchymal stem cells derived from bone marrow or adipose tissue. J Cell Biochem (2019) 120: 11842–52.
    doi: 10.1002/jcb.28463pubmed: 30746760google scholar: lookup
  44. Guercio A, Di Bella S, Casella S, Di Marco P, Russo C, Piccione G. Canine mesenchymal stem cells (MSCs): characterization in relation to donor age and adipose tissue-harvesting site. Cell Biol Int (2013) 37:789–98.
    doi: 10.1002/cbin.10090pubmed: 23505013google scholar: lookup
  45. Yaneselli KM, Kuhl CP, Terraciano PB, de Oliveira FS, Pizzato SB, Pazza K. Comparison of the characteristics of canine adipose tissue-derived mesenchymal stem cells extracted from different sites and at different passage numbers. J Vet Sci (2018) 19:13–20.
    doi: 10.4142/jvs.2018.19.1.13pmc: PMC5799390pubmed: 28693305google scholar: lookup
  46. Bahamondes F, Flores E, Cattaneo G, Bruna F, Conget P. Omental adipose tissue is a more suitable source of canine mesenchymal stem cells. BMC Vet Res (2017) 13:166.
    doi: 10.1186/s12917-017-1053-0pmc: PMC5465460pubmed: 28595579google scholar: lookup
  47. Boxall SA, Jones E. Markers for characterization of bone marrow multipotential stromal cells. Stem Cells Int (2012) 2012:975871.
    doi: 10.1155/2012/975871pmc: PMC3361338pubmed: 22666272google scholar: lookup
  48. FDA nCVM GFI #218 Cell-Based Products for Animal Use. (2015). Available online at: https://www.fda.gov/media/88925/download (accessed February 15, 2020).
  49. Sancak IG, Ozen A, Bayraktaroglu AG, Ceylan A, Can P. Characterization of mesenchymal stem cells isolated from the adipose tissue of young and old dogs. Veteriner Fakültesi dergisi (2016) 63:297–302.
    doi: 10.1501/Vetfak_0000002743google scholar: lookup
  50. Zajic B, Webb LT, Webb P, Coy WJ, Quimby MJ. Comparison of proliferative and immunomodulatory potential of adipose-derived mesenchymal stem cells from young and geriatric cats. J Feline Med Surg (2017) 19:1096–102.
    doi: 10.1177/1098612X16680703pmc: PMC11110994pubmed: 27913779google scholar: lookup
  51. Taguchi T, Borjesson DL, Osmond C, Griffon DJ. Influence of donor's age on immunomodulatory properties of canine adipose tissue-derived mesenchymal stem cells. Stem Cells Dev (2019) 28:1562–71.
    doi: 10.1089/scd.2019.0118pubmed: 31588862google scholar: lookup
  52. Iohara K, Murakami M, Nakata K, Nakashima M. Age-dependent decline in dental pulp regeneration after pulpectomy in dogs. Exp Gerontol (2014) 52:39–45.
    doi: 10.1016/j.exger.2014.01.020pubmed: 24468330google scholar: lookup
  53. Lee J, Lee KS, Kim CL, Byeon JS, Gu NY, Cho IS. Effect of donor age on the proliferation and multipotency of canine adipose-derived mesenchymal stem cells. J Vet Sci (2017) 18:141–8.
    doi: 10.4142/jvs.2017.18.2.141pmc: PMC5489460pubmed: 27456768google scholar: lookup
  54. Marycz K, Kornicka K, Maredziak M, Golonka P, Nicpon J. Equine metabolic syndrome impairs adipose stem cells osteogenic differentiation by predominance of autophagy over selective mitophagy. J Cell Mol Med (2016) 20:2384–404.
    doi: 10.1111/jcmm.12932pmc: PMC5134411pubmed: 27629697google scholar: lookup
  55. Wieczorek M, Abualrous ET, Sticht J, Alvaro-Benito M, Stolzenberg S, Noe F. Major histocompatibility complex (MHC) class I and MHC class II proteins: conformational plasticity in antigen presentation. Front Immunol (2017) 8:292.
    doi: 10.3389/fimmu.2017.00292pmc: PMC5355494pubmed: 28367149google scholar: lookup
  56. Schnabel LV, Pezzanite LM, Antczak DF, Felippe JB, Fortier LA. Equine bone marrow-derived mesenchymal stromal cells are heterogeneous in MHC class II expression and capable of inciting an immune response in vitro. Stem Cell Res Ther (2014) 5:13.
    doi: 10.1186/scrt402pmc: PMC4055004pubmed: 24461709google scholar: lookup
  57. Berglund AK, Schnabel LV. Allogeneic major histocompatibility complex-mismatched equine bone marrow-derived mesenchymal stem cells are targeted for death by cytotoxic anti-major histocompatibility complex antibodies. Equine Vet J (2017) 49:539–44.
    doi: 10.1111/evj.12647pmc: PMC5425313pubmed: 27862236google scholar: lookup
  58. Oliveira RL, Chagastelles PC, Sesterheim P, Pranke P. In vivo immunogenic response to allogeneic mesenchymal stem cells and the role of preactivated mesenchymal stem cells cotransplanted with allogeneic islets. Stem Cells Int (2017) 2017:9824698.
    doi: 10.1155/2017/9824698pmc: PMC5434460pubmed: 28553360google scholar: lookup
  59. Ryan AE, Lohan P, O'Flynn L, Treacy O, Chen X, Coleman C. Chondrogenic differentiation increases antidonor immune response to allogeneic mesenchymal stem cell transplantation. Mol Ther (2014) 22:655–67.
    doi: 10.1038/mt.2013.261pmc: PMC3944342pubmed: 24184966google scholar: lookup
  60. Joswig AJ, Mitchell A, Cummings KJ, Levine GJ, Gregory CA, Smith R. Repeated intra-articular injection of allogeneic mesenchymal stem cells causes an adverse response compared to autologous cells in the equine model. Stem Cell Res Ther (2017) 8:42.
    doi: 10.1186/s13287-017-0503-8pmc: PMC5329965pubmed: 28241885google scholar: lookup
  61. Pezzanite LM, Fortier LA, Antczak DF, Cassano JM, Brosnahan MM, Miller D. Equine allogeneic bone marrow-derived mesenchymal stromal cells elicit antibody responses in vivo. Stem Cell Res Ther (2015) 6:54.
    doi: 10.1186/s13287-015-0053-xpmc: PMC4414005pubmed: 25889095google scholar: lookup
  62. Ursini TL, Amelse LL, Elkhenany HA, Odoi A, Carter-Arnold JL, Adair HS. Retrospective analysis of local injection site adverse reactions associated with 230 allogenic administrations of bone marrow-derived mesenchymal stem cells in 164 horses. Equine Vet J (2019) 51:198–205.
    doi: 10.1111/evj.12992pubmed: 29992618google scholar: lookup
  63. Cabon Q, Febre M, Gomez N, Cachon T, Pillard P, Carozzo C. Long-term safety and efficacy of single or repeated intra-articular injection of allogeneic neonatal mesenchymal stromal cells for managing pain and lameness in moderate to severe canine osteoarthritis without anti-inflammatory pharmacological support: pilot clinical study. Front Vet Sci (2019) 6:10.
    doi: 10.3389/fvets.2019.00010pmc: PMC6371748pubmed: 30805348google scholar: lookup
  64. Bertoni L, Branly T, Jacquet S, Desance M, Desquilbet L, Rivory P. Intra-articular injection of 2 different dosages of autologous and allogeneic bone marrow- and umbilical cord-derived mesenchymal stem cells triggers a variable inflammatory response of the fetlock joint on 12 sound experimental horses. Stem Cells Int (2019) 2019:9431894.
    doi: 10.1155/2019/9431894pmc: PMC6525957pubmed: 31191689google scholar: lookup
  65. Magri C, Schramme M, Febre M, Cauvin E, Labadie F, Saulnier N. Comparison of efficacy and safety of single versus repeated intra-articular injection of allogeneic neonatal mesenchymal stem cells for treatment of osteoarthritis of the metacarpophalangeal/metatarsophalangeal joint in horses: a clinical pilot study. PLoS ONE (2019) 14:e0221317.
    doi: 10.1371/journal.pone.0221317pmc: PMC6715221pubmed: 31465445google scholar: lookup
  66. Menard C, Dulong J, Roulois D, Hebraud B, Verdiere L, Pangault C. Integrated transcriptomic, phenotypic, and functional study reveals tissue-specific immune properties of mesenchymal stromal cells. Stem Cells (2019) 38:146–59.
    doi: 10.1002/stem.3077pubmed: 31502731google scholar: lookup
  67. Souza-Moreira L, Soares VC, Dias S, Bozza PT. Adipose-derived mesenchymal stromal cells modulate lipid metabolism and lipid droplet biogenesis via AKT/mTOR -PPARγ signalling in macrophages. Sci Rep (2019) 9:20304.
    doi: 10.1038/s41598-019-56835-8pmc: PMC6937267pubmed: 31889120google scholar: lookup
  68. Gao WX, Sun YQ, Shi J, Li CL, Fang SB, Wang D. Effects of mesenchymal stem cells from human induced pluripotent stem cells on differentiation, maturation, and function of dendritic cells. Stem Cell Res Ther (2017) 8:48.
    doi: 10.1186/s13287-017-0499-0pmc: PMC5333407pubmed: 28253916google scholar: lookup
  69. Laing AG, Fanelli G, Ramirez-Valdez A, Lechler RI, Lombardi G, Sharpe PT. Mesenchymal stem cells inhibit T-cell function through conserved induction of cellular stress. PLoS ONE (2019) 14:e0213170.
    doi: 10.1371/journal.pone.0213170pmc: PMC6417714pubmed: 30870462google scholar: lookup
  70. Luk F, Carreras-Planella L, Korevaar SS, de Witte SFH, Borras FE, Betjes MGH. Inflammatory conditions dictate the effect of mesenchymal stem or stromal cells on B cell function. Front Immunol (2017) 8:1042.
    doi: 10.3389/fimmu.2017.01042pmc: PMC5581385pubmed: 28894451google scholar: lookup
  71. Spaggiari GM, Capobianco A, Becchetti S, Mingari MC, Moretta L. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood (2006) 107:1484–90.
    doi: 10.1182/blood-2005-07-2775pubmed: 16239427google scholar: lookup
  72. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med (2000) 342:1350–8.
    doi: 10.1056/NEJM200005043421807pubmed: 10793168google scholar: lookup
  73. Deng M, Mei T, Hou T, Luo K, Luo F, Yang A. TGFβ3 recruits endogenous mesenchymal stem cells to initiate bone regeneration. Stem Cell Res Ther (2017) 8:258.
    doi: 10.1186/s13287-017-0693-0pmc: PMC5681754pubmed: 29126441google scholar: lookup
  74. Dubon MJ, Yu J, Choi S, Park KS. Transforming growth factor beta induces bone marrow mesenchymal stem cell migration via noncanonical signals and N-cadherin. J Cell Physiol (2018) 233:201–13.
    doi: 10.1002/jcp.25863pubmed: 28213973google scholar: lookup
  75. Liu F, Qiu H, Xue M, Zhang S, Zhang X, Xu J. MSC-secreted TGF-β regulates lipopolysaccharide-stimulated macrophage M2-like polarization via the Akt/FoxO1 pathway. Stem Cell Res Ther (2019) 10:345.
    doi: 10.1186/s13287-019-1447-ypmc: PMC6878630pubmed: 31771622google scholar: lookup
  76. Wu R, Liu C, Deng X, Chen L, Hao S, Ma L. Enhanced alleviation of aGVHD by TGF-β1-modified mesenchymal stem cells in mice through shifting MPhi into M2 phenotype and promoting the differentiation of Treg cells. J Cell Mol Med (2020) 24:1684–99.
    doi: 10.1111/jcmm.14862pmc: PMC6991663pubmed: 31782262google scholar: lookup
  77. Gazdic M, Markovic BS, Arsenijevic A, Jovicic N, Acovic A, Harrell CR. Crosstalk between mesenchymal stem cells and T regulatory cells is crucially important for the attenuation of acute liver injury. Liver Transpl (2018) 24:687–702.
    doi: 10.1002/lt.25049pubmed: 29500914google scholar: lookup
  78. Schmidt A, Zhang XM, Joshi RN, Iqbal S, Wahlund C, Gabrielsson S. Human macrophages induce CD4(+)Foxp3(+) regulatory T cells via binding and re-release of TGF-β. Immunol Cell Biol (2016) 94:747–62.
    doi: 10.1038/icb.2016.34pubmed: 27075967google scholar: lookup
  79. Melief SM, Schrama E, Brugman MH, Tiemessen MM, Hoogduijn MJ, Fibbe WE. Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages. Stem Cells (2013) 31:1980–91.
    doi: 10.1002/stem.1432pubmed: 23712682google scholar: lookup
  80. Franquesa M, Mensah FK, Huizinga R, Strini T, Boon L, Lombardo E. Human adipose tissue-derived mesenchymal stem cells abrogate plasmablast formation and induce regulatory B cells independently of T helper cells. Stem Cells (2015) 33:880–91.
    doi: 10.1002/stem.1881pubmed: 25376628google scholar: lookup
  81. Fallarino F, Grohmann U, You S, McGrath BC, Cavener DR, Vacca C. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J Immunol (2006) 176:6752–61.
    doi: 10.4049/jimmunol.176.11.6752pubmed: 16709834google scholar: lookup
  82. Spaggiari GM, Capobianco A, Abdelrazik H, Becchetti F, Mingari MC, Moretta L. Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood (2008) 111:1327–33.
    doi: 10.1182/blood-2007-02-074997pubmed: 17951526google scholar: lookup
  83. Francois M, Romieu-Mourez R, Li M, Galipeau J. Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation. Mol Ther (2012) 20:187–95.
    doi: 10.1038/mt.2011.189pubmed: 21934657google scholar: lookup
  84. Kalinski P. Regulation of immune responses by prostaglandin E2. J Immunol (2012) 188:21–8.
    doi: 10.4049/jimmunol.1101029pmc: PMC3249979pubmed: 22187483google scholar: lookup
  85. Jin L, Deng Z, Zhang J, Yang C, Liu J, Han W. Mesenchymal stem cells promote type 2 macrophage polarization to ameliorate the myocardial injury caused by diabetic cardiomyopathy. J Transl Med (2019) 17:251.
    doi: 10.1186/s12967-019-1999-8pmc: PMC6683374pubmed: 31382970google scholar: lookup
  86. Zhang Z, Huang S, Wu S, Qi J, Li W, Liu S. Clearance of apoptotic cells by mesenchymal stem cells contributes to immunosuppression via PGE2. EBioMedicine (2019) 45:341–50.
    doi: 10.1016/j.ebiom.2019.06.016pmc: PMC6642220pubmed: 31248835google scholar: lookup
  87. de Vries JE. Immunosuppressive and anti-inflammatory properties of interleukin 10. Ann Med (1995) 27:537–41.
    doi: 10.3109/07853899509002465pubmed: 8541028google scholar: lookup
  88. Couper KN, Blount DG, Riley EM. IL-10: the master regulator of immunity to infection. J Immunol (2008) 180:5771–7.
    doi: 10.4049/jimmunol.180.9.5771pubmed: 18424693google scholar: lookup
  89. Najar M, Raicevic G, Fayyad-Kazan H, De Bruyn C, Bron D, Toungouz M. Bone marrow mesenchymal stromal cells induce proliferative, cytokinic and molecular changes during the T cell response: the importance of the IL-10/CD210 axis. Stem Cell Rev Rep (2015) 11:442–52.
    doi: 10.1007/s12015-014-9567-3pubmed: 25326368google scholar: lookup
  90. Day AJ, Milner CM. TSG-6: a multifunctional protein with anti-inflammatory and tissue-protective properties. Matrix Biol (2019) 78–9:60–83.
    doi: 10.1016/j.matbio.2018.01.011pubmed: 29362135google scholar: lookup
  91. Romano B, Elangovan S, Erreni M, Sala E, Petti L, Kunderfranco P. TNF-stimulated gene-6 is a key regulator in switching stemness and biological properties of mesenchymal stem cells. Stem Cells (2019) 37:973–87.
    doi: 10.1002/stem.3010pubmed: 30942926google scholar: lookup
  92. An JH, Li Q, Bhang DH, Song WJ, Youn HY. TNF-α and INF-γ primed canine stem cell-derived extracellular vesicles alleviate experimental murine colitis. Sci Rep (2020) 10:2115.
    doi: 10.1038/s41598-020-58909-4pmc: PMC7005871pubmed: 32034203google scholar: lookup
  93. Song WJ, Li Q, Ryu MO, Ahn JO, Bhang DH, Jung YC. TSG-6 released from intraperitoneally injected canine adipose tissue-derived mesenchymal stem cells ameliorate inflammatory bowel disease by inducing M2 macrophage switch in mice. Stem Cell Res Ther (2018) 9:91.
    doi: 10.1186/s13287-018-0841-1pmc: PMC5889600pubmed: 29625582google scholar: lookup
  94. Wang S, Lee JS, Hyun J, Kim J, Kim SU, Cha HJ. Tumor necrosis factor-inducible gene 6 promotes liver regeneration in mice with acute liver injury. Stem Cell Res Ther (2015) 6:20.
    doi: 10.1186/s13287-015-0019-zpmc: PMC4396561pubmed: 25890163google scholar: lookup
  95. Um S, Kim HY, Lee JH, Song IS, Seo BM. TSG-6 secreted by mesenchymal stem cells suppresses immune reactions influenced by BMP-2 through p38 and MEK mitogen-activated protein kinase pathway. Cell Tissue Res (2017) 368:551–61.
    doi: 10.1007/s00441-017-2581-4pubmed: 28247086google scholar: lookup
  96. Abels ER, Breakefield XO. Introduction to extracellular vesicles: biogenesis, RNA cargo selection, content, release, and uptake. Cell Mol Neurobiol (2016) 36:301–12.
    doi: 10.1007/s10571-016-0366-zpmc: PMC5546313pubmed: 27053351google scholar: lookup
  97. Jung JW, Kwon M, Choi JC, Shin JW, Park IW, Choi BW. Familial occurrence of pulmonary embolism after intravenous, adipose tissue-derived stem cell therapy. Yonsei Med J (2013) 54:1293–6.
    doi: 10.3349/ymj.2013.54.5.1293pmc: PMC3743204pubmed: 23918585google scholar: lookup
  98. Makela T, Takalo R, Arvola O, Haapanen H, Yannopoulos F, Blanco R. Safety and biodistribution study of bone marrow-derived mesenchymal stromal cells and mononuclear cells and the impact of the administration route in an intact porcine model. Cytotherapy (2015) 17:392–402.
    doi: 10.1016/j.jcyt.2014.12.004pubmed: 25601140google scholar: lookup
  99. Kalra H, Drummen GP, Mathivanan S. Focus on extracellular vesicles: introducing the next small big thing. Int J Mol Sci (2016) 17:170.
    doi: 10.3390/ijms17020170pmc: PMC4783904pubmed: 26861301google scholar: lookup
  100. Lai RC, Tan SS, Yeo RW, Choo AB, Reiner AT, Su Y. MSC secretes at least 3 EV types each with a unique permutation of membrane lipid, protein and RNA. J Extracell Vesicles (2016) 5:29828.
    doi: 10.3402/jev.v5.29828pmc: PMC4770866pubmed: 26928672google scholar: lookup
  101. Hyvarinen K, Holopainen M, Skirdenko V, Ruhanen H, Lehenkari P, Korhonen M. Mesenchymal stromal cells and their extracellular vesicles enhance the anti-inflammatory phenotype of regulatory macrophages by downregulating the production of interleukin (IL)-23 and IL-22. Front Immunol (2018) 9:771.
    doi: 10.3389/fimmu.2018.00771pmc: PMC5906545pubmed: 29706969google scholar: lookup
  102. Crain SK, Robinson SR, Thane KE, Davis AM, Meola DM, Barton BA. Extracellular vesicles from Wharton's Jelly mesenchymal stem cells suppress CD4 expressing T cells through transforming growth factor beta and adenosine signaling in a canine model. Stem Cells Dev (2019) 28:212–26.
    doi: 10.1089/scd.2018.0097pubmed: 30412034google scholar: lookup
  103. Park KS, Svennerholm K, Shelke GV, Bandeira E, Lasser C, Jang SC. Mesenchymal stromal cell-derived nanovesicles ameliorate bacterial outer membrane vesicle-induced sepsis via IL-10. Stem Cell Res Ther (2019) 10:231.
    doi: 10.1186/s13287-019-1352-4pmc: PMC6676541pubmed: 31370884google scholar: lookup
  104. Khatri M, Richardson LA, Meulia T. Mesenchymal stem cell-derived extracellular vesicles attenuate influenza virus-induced acute lung injury in a pig model. Stem Cell Res Ther (2018) 9:17.
    doi: 10.1186/s13287-018-0774-8pmc: PMC5789598pubmed: 29378639google scholar: lookup
  105. Eirin A, Zhu XY, Puranik AS, Tang H, McGurren KA, van Wijnen AJ. Mesenchymal stem cell-derived extracellular vesicles attenuate kidney inflammation. Kidney Int (2017) 92:114–24.
    doi: 10.1016/j.kint.2016.12.023pmc: PMC5483390pubmed: 28242034google scholar: lookup
  106. Haga H, Yan IK, Takahashi K, Matsuda A, Patel T. Extracellular vesicles from bone marrow-derived mesenchymal stem cells improve survival from lethal hepatic failure in mice. Stem Cells Transl Med (2017) 6:1262–72.
    doi: 10.1002/sctm.16-0226pmc: PMC5442843pubmed: 28213967google scholar: lookup
  107. Cosenza S, Ruiz M, Toupet K, Jorgensen C, Noel D. Mesenchymal stem cells derived exosomes and microparticles protect cartilage and bone from degradation in osteoarthritis. Sci Rep (2017) 7:16214.
    doi: 10.1038/s41598-017-15376-8pmc: PMC5701135pubmed: 29176667google scholar: lookup
  108. Ruppert KA, Nguyen TT, Prabhakara KS, Toledano Furman NE, Srivastava AK, Harting MT. Human mesenchymal stromal cell-derived extracellular vesicles modify microglial response and improve clinical outcomes in experimental spinal cord injury. Sci Rep (2018) 8:480.
    doi: 10.1038/s41598-017-18867-wpmc: PMC5764957pubmed: 29323194google scholar: lookup
  109. Deng M, Xiao H, Zhang H, Peng H, Yuan H, Xu Y. Mesenchymal stem cell-derived extracellular vesicles ameliorates hippocampal synaptic impairment after transient global ischemia. Front Cell Neurosci (2017) 11:205.
    doi: 10.3389/fncel.2017.00205pmc: PMC5511812pubmed: 28769765google scholar: lookup
  110. Liu L, Jin X, Hu CF, Li R, Zhou Z, Shen CX. Exosomes derived from mesenchymal stem cells rescue myocardial ischaemia/reperfusion injury by inducing cardiomyocyte autophagy via AMPK and Akt pathways. Cell Physiol Biochem (2017) 43:52–68.
    doi: 10.1159/000480317pubmed: 28848091google scholar: lookup
  111. Kornicka-Garbowska K, Pedziwiatr R, Wozniak P, Kucharczyk K, Marycz K. Microvesicles isolated from 5-azacytidine-and-resveratrol-treated mesenchymal stem cells for the treatment of suspensory ligament injury in horse-a case report. Stem Cell Res Ther (2019) 10:394.
    doi: 10.1186/s13287-019-1469-5pmc: PMC6921487pubmed: 31852535google scholar: lookup
  112. El-Tookhy OS, Shamaa AA, Shehab GG, Abdallah AN, Azzam OM. Histological evaluation of experimentally induced critical size defect skin wounds using exosomal solution of mesenchymal stem cells derived microvesicles. Int J Stem Cells (2017) 10:144–53.
    doi: 10.15283/ijsc17043pmc: PMC5741195pubmed: 29084422google scholar: lookup
  113. Fu QL, Chow YY, Sun SJ, Zeng QX, Li HB, Shi JB. Mesenchymal stem cells derived from human induced pluripotent stem cells modulate T-cell phenotypes in allergic rhinitis. Allergy (2012) 67:1215–22.
    doi: 10.1111/j.1398-9995.2012.02875.xpmc: PMC3555482pubmed: 22882409google scholar: lookup
  114. Luk F, de Witte SF, Korevaar SS, Roemeling-van Rhijn M, Franquesa M, Strini T. Inactivated mesenchymal stem cells maintain immunomodulatory capacity. Stem Cells Dev (2016) 25:1342–54.
    doi: 10.1089/scd.2016.0068pubmed: 27349989google scholar: lookup
  115. Tan SS, Yin Y, Lee T, Lai RC, Yeo RW, Zhang B. Therapeutic MSC exosomes are derived from lipid raft microdomains in the plasma membrane. J Extracell Vesicles (2013) 2:22614.
    doi: 10.3402/jev.v2i0.22614pmc: PMC3873122pubmed: 24371518google scholar: lookup
  116. Toh WS, Zhang B, Lai RC, Lim SK. Immune regulatory targets of mesenchymal stromal cell exosomes/small extracellular vesicles in tissue regeneration. Cytotherapy (2018) 20:1419–26.
    doi: 10.1016/j.jcyt.2018.09.008pubmed: 30352735google scholar: lookup
  117. Reiner AT, Witwer KW, van Balkom BWM, de Beer J, Brodie C, Corteling RL. Concise review: developing best-practice models for the therapeutic use of extracellular vesicles. Stem Cells Transl Med (2017) 6:1730–9.
    doi: 10.1002/sctm.17-0055pmc: PMC5689784pubmed: 28714557google scholar: lookup
  118. Thery C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R. Minimal information for studies of extracellular vesicles 2018. (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles (2018) 7:1535750.
    doi: 10.1080/20013078.2018.1461450pmc: PMC6322352pubmed: 30637094google scholar: lookup
  119. Elliott MR, Koster KM, Murphy PS. Efferocytosis signaling in the regulation of macrophage inflammatory responses. J Immunol (2017) 198:1387–94.
    doi: 10.4049/jimmunol.1601520pmc: PMC5301545pubmed: 28167649google scholar: lookup
  120. Galleu A, Riffo-Vasquez Y, Trento C, Lomas C, Dolcetti L, Cheung TS. Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation. Sci Transl Med (2017) 9:eaam7828.
    doi: 10.1126/scitranslmed.aam7828pubmed: 29141887google scholar: lookup
  121. Cheung TS, Galleu A, von Bonin M, Bornhauser M, Dazzi F. Apoptotic mesenchymal stromal cells induce prostaglandin E2 in monocytes: implications for the monitoring of mesenchymal stromal cell activity. Haematologica (2019) 104:e438–41.
    doi: 10.3324/haematol.2018.214767pmc: PMC6886441pubmed: 30846505google scholar: lookup
  122. de Witte SFH, Luk F, Sierra Parraga JM, Gargesha M, Merino A, Korevaar SS. Immunomodulation by therapeutic mesenchymal stromal cells (MSC) is triggered through phagocytosis of MSC by monocytic cells. Stem Cells (2018) 36:602–15.
    doi: 10.1002/stem.2779pubmed: 29341339google scholar: lookup
  123. Spees JL, Olson SD, Whitney MJ, Prockop DJ. Mitochondrial transfer between cells can rescue aerobic respiration. Proc Natl Acad Sci USA (2006) 103:1283–8.
    doi: 10.1073/pnas.0510511103pmc: PMC1345715pubmed: 16432190google scholar: lookup
  124. Jackson MV, Morrison TJ, Doherty DF, McAuley DF, Matthay MA, Kissenpfennig A. Mitochondrial transfer via tunneling nanotubes is an important mechanism by which mesenchymal stem cells enhance macrophage phagocytosis in the in vitro and in vivo models of ARDS. Stem Cells (2016) 34:2210–23.
    doi: 10.1002/stem.2372pmc: PMC4982045pubmed: 27059413google scholar: lookup
  125. Li C, Cheung MKH, Han S, Zhang Z, Chen L, Chen J. Mesenchymal stem cells and their mitochondrial transfer: a double-edged sword. Biosci Rep (2019) 39:BSR20182417.
    doi: 10.1042/BSR20182417pmc: PMC6500894pubmed: 30979829google scholar: lookup
  126. Penn MS. SDF-1:CXCR4 axis is fundamental for tissue preservation and repair. Am J Pathol (2010) 177:2166–8.
    doi: 10.2353/ajpath.2010.100803pmc: PMC2966775pubmed: 20889567google scholar: lookup
  127. Wynn RF, Hart CA, Corradi-Perini C, O'Neill L, Evans CA, Wraith JE. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood (2004) 104:2643–5.
    doi: 10.1182/blood-2004-02-0526pubmed: 15251986google scholar: lookup
  128. Chamberlain G, Wright K, Rot A, Ashton B, Middleton J. Murine mesenchymal stem cells exhibit a restricted repertoire of functional chemokine receptors: comparison with human. PLoS ONE (2008) 3:e2934.
    doi: 10.1371/journal.pone.0002934pmc: PMC2488395pubmed: 18698345google scholar: lookup
  129. Zou C, Song G, Luo Q, Yuan L, Yang L. Mesenchymal stem cells require integrin β1 for directed migration induced by osteopontin in vitro. In Vitro Cell Dev Biol Anim (2011) 47:241–50.
    doi: 10.1007/s11626-010-9377-0pubmed: 21136191google scholar: lookup
  130. Wang X, Zhen L, Miao H, Sun Q, Yang Y, Que B. Concomitant retrograde coronary venous infusion of basic fibroblast growth factor enhances engraftment and differentiation of bone marrow mesenchymal stem cells for cardiac repair after myocardial infarction. Theranostics (2015) 5:995–1006.
    doi: 10.7150/thno.11607pmc: PMC4493537pubmed: 26155315google scholar: lookup
  131. Ball SG, Shuttleworth CA, Kielty CM. Vascular endothelial growth factor can signal through platelet-derived growth factor receptors. J Cell Biol (2007) 177:489–500.
    doi: 10.1083/jcb.200608093pmc: PMC2064818pubmed: 17470632google scholar: lookup
  132. Forte G, Minieri M, Cossa P, Antenucci D, Sala M, Gnocchi V. Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation. Stem Cells (2006) 24:23–33.
    doi: 10.1634/stemcells.2004-0176pubmed: 16100005google scholar: lookup
  133. Xinaris C, Morigi M, Benedetti V, Imberti B, Fabricio AS, Squarcina E. A novel strategy to enhance mesenchymal stem cell migration capacity and promote tissue repair in an injury specific fashion. Cell Transplant (2013) 22:423–36.
    doi: 10.3727/096368912X653246pubmed: 22889699google scholar: lookup
  134. Gao P, Zhou Y, Xian L, Li C, Xu T, Plunkett B. Functional effects of TGF-β1 on mesenchymal stem cell mobilization in cockroach allergen-induced asthma. J Immunol (2014) 192:4560–70.
    doi: 10.4049/jimmunol.1303461pmc: PMC4039654pubmed: 24711618google scholar: lookup
  135. Fu X, Liu G, Halim A, Ju Y, Luo Q, Song AG. Mesenchymal stem cell migration and tissue repair. Cells (2019) 8:784.
    doi: 10.3390/cells8080784pmc: PMC6721499pubmed: 31357692google scholar: lookup
  136. Nowakowski A, Walczak P, Lukomska B, Janowski M. Genetic engineering of mesenchymal stem cells to induce their migration and survival. Stem Cells Int (2016) 2016:4956063.
    doi: 10.1155/2016/4956063pmc: PMC4868914pubmed: 27242906google scholar: lookup
  137. Ullah M, Liu DD, Thakor AS. Mesenchymal stromal cell homing: mechanisms and strategies for improvement. iScience (2019) 15:421–38.
    doi: 10.1016/j.isci.2019.05.004pmc: PMC6529790pubmed: 31121468google scholar: lookup
  138. Gao J, Dennis JE, Muzic RF, Lundberg M, Caplan AI. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs (2001) 169:12–20.
    doi: 10.1159/000047856pubmed: 11340257google scholar: lookup
  139. Eggenhofer E, Benseler V, Kroemer A, Popp FC, Geissler EK, Schlitt HJ. Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion. Front Immunol (2012) 3:297.
    doi: 10.3389/fimmu.2012.00297pmc: PMC3458305pubmed: 23056000google scholar: lookup
  140. Jasmin, Jelicks LA, Tanowitz HB, Peters VM, Mendez-Otero R, de Carvalho ACC. Molecular imaging, biodistribution and efficacy of mesenchymal bone marrow cell therapy in a mouse model of Chagas disease. Microbes Infect (2014) 16:923–35.
    doi: 10.1016/j.micinf.2014.08.016pmc: PMC4360918pubmed: 25218054google scholar: lookup
  141. Kraitchman DL, Tatsumi M, Gilson WD, Ishimori T, Kedziorek D, Walczak P. Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation (2005) 112:1451–61.
    doi: 10.1161/CIRCULATIONAHA.105.537480pmc: PMC1456731pubmed: 16129797google scholar: lookup
  142. Yan Y, Fang J, Wen X, Teng X, Li B, Zhou Z. Therapeutic applications of adipose-derived mesenchymal stem cells on acute liver injury in canines. Res Vet Sci (2019) 126:233–9.
    doi: 10.1016/j.rvsc.2019.09.004pubmed: 31635840google scholar: lookup
  143. Wang S, Guo L, Ge J, Yu L, Cai T, Tian R. Excess integrins cause lung entrapment of mesenchymal stem cells. Stem Cells (2015) 33:3315–26.
    doi: 10.1002/stem.2087pubmed: 26148841google scholar: lookup
  144. Abe T, Sumi K, Kunimatsu R, Oki N, Tsuka Y, Awada T. Bone regeneration in a canine model of artificial jaw cleft using bone marrow-derived mesenchymal stem cells and carbonate hydroxyapatite carrier. Cleft Palate Craniofac J (2020) 57:208–17.
    doi: 10.1177/1055665619868868pubmed: 31422673google scholar: lookup
  145. Sole A, Spriet M, Padgett KA, Vaughan B, Galuppo LD, Borjesson DL. Distribution and persistence of technetium-99 hexamethyl propylene amine oxime-labelled bone marrow-derived mesenchymal stem cells in experimentally induced tendon lesions after intratendinous injection and regional perfusion of the equine distal limb. Equine Vet J (2013) 45:726–31.
    doi: 10.1111/evj.12063pubmed: 23574488google scholar: lookup
  146. Walczak P, Zhang J, Gilad AA, Kedziorek DA, Ruiz-Cabello J, Young RG. Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke (2008) 39:1569–74.
    doi: 10.1161/STROKEAHA.107.502047pmc: PMC2857730pubmed: 18323495google scholar: lookup
  147. Trela JM, Spriet M, Padgett KA, Galuppo LD, Vaughan B, Vidal MA. Scintigraphic comparison of intra-arterial injection and distal intravenous regional limb perfusion for administration of mesenchymal stem cells to the equine foot. Equine Vet J (2014) 46:479–83.
    doi: 10.1111/evj.12137pubmed: 23834199google scholar: lookup
  148. Torrent A, Spriet M, Espinosa-Mur P, Clark KC, Whitcomb MB, Borjesson DL. Ultrasound-guided injection of the cranial tibial artery for stem cell administration in horses. Equine Vet J (2019) 51:681–7.
    doi: 10.1111/evj.13065pubmed: 30623489google scholar: lookup
  149. Nishimura T, Takami T, Sasaki R, Aibe Y, Matsuda T, Fujisawa K. Liver regeneration therapy through the hepatic artery-infusion of cultured bone marrow cells in a canine liver fibrosis model. PLoS ONE (2019) 14:e0210588.
    doi: 10.1371/journal.pone.0210588pmc: PMC6343920pubmed: 30673721google scholar: lookup
  150. Parys M, Nelson N, Koehl K, Miller R, Kaneene JB, Kruger JM. Safety of intraperitoneal injection of adipose tissue-derived autologous mesenchymal stem cells in cats. J Vet Intern Med (2016) 30:157–63.
    doi: 10.1111/jvim.13655pmc: PMC4913639pubmed: 26512713google scholar: lookup
  151. Wiafe B, Kadam R, Metcalfe PD. Intraperitoneal administration of mesenchymal stem cells is effective at mitigating detrusor deterioration after pBOO. Am J Physiol Renal Physiol (2020) 318:F549–56.
    doi: 10.1152/ajprenal.00486.2019pubmed: 31904287google scholar: lookup
  152. Gooch A, Zhang P, Hu Z, Loy Son N, Avila N, Fischer J. Interim report on the effective intraperitoneal therapy of insulin-dependent diabetes mellitus in pet dogs using “Neo-Islets,” aggregates of adipose stem and pancreatic islet cells (INAD 012-776). PLoS ONE (2019) 14:e0218688.
    doi: 10.1371/journal.pone.0218688pmc: PMC6752848pubmed: 31536503google scholar: lookup
  153. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringdén O. HLA expression and immunologic propertiesof differentiated and undifferentiated mesenchymal stem cells. Exp Hematol (2003) 31:890–6.
    doi: 10.1016/S0301-472X(03)00110-3pubmed: 14550804google scholar: lookup
  154. Klyushnenkova E, Mosca JD, Zernetkina V, Majumdar MK, Beggs KJ, Simonetti DW. T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. J Biomed Sci (2005) 12:47–57.
    doi: 10.1007/s11373-004-8183-7pubmed: 15864738google scholar: lookup
  155. van Megen KM, van 't Wout ET, Lages Motta J, Dekker B, Nikolic T, Roep BO. Activated mesenchymal stromal cells process and present antigens regulating adaptive immunity. Front Immunol (2019) 10:694.
    doi: 10.3389/fimmu.2019.00694pmc: PMC6457321pubmed: 31001285google scholar: lookup
  156. Sivanathan KN, Rojas-Canales D, Grey ST, Gronthos S, Coates PT. Transcriptome profiling of IL-17A preactivated mesenchymal stem cells: a comparative study to unmodified and IFN-γ modified mesenchymal stem cells. Stem Cells Int (2017) 2017:1025820.
    doi: 10.1155/2017/1025820pmc: PMC5331321pubmed: 28293262google scholar: lookup
  157. Li X, Shang B, Li YN, Shi Y, Shao C. IFNγ and TNFα synergistically induce apoptosis of mesenchymal stem/stromal cells via the induction of nitric oxide. Stem Cell Res Ther (2019) 10:18.
    doi: 10.1186/s13287-018-1102-zpmc: PMC6330503pubmed: 30635041google scholar: lookup
  158. Brandt L, Schubert S, Scheibe P, Brehm W, Franzen J, Gross C. Tenogenic properties of mesenchymal progenitor cells are compromised in an inflammatory environment. Int J Mol Sci (2018) 19:2549.
    doi: 10.3390/ijms19092549pmc: PMC6163784pubmed: 30154348google scholar: lookup
  159. Dakin SG, Jespers K, Warner S, O'Hara LK, Dudhia J, Goodship AE. The relationship between in vivo limb and in vitro tendon mechanics after injury: a potential novel clinical tool for monitoring tendon repair. Equine Vet J (2011) 43:418–23.
    doi: 10.1111/j.2042-3306.2010.00303.xpubmed: 21496076google scholar: lookup
  160. Dyson SJ. Medical management of superficial digital flexor tendonitis: a comparative study in 219 horses (1992-2000). Equine Vet J (2004) 36:415–9.
    doi: 10.2746/0425164044868422pubmed: 15253082google scholar: lookup
  161. Petrov R, MacDonald MH, Tesch AM, Van Hoogmoed LM. Influence of topically applied cold treatment on core temperature and cell viability in equine superficial digital flexor tendons. Am J Vet Res (2003) 64:835–44.
    doi: 10.2460/ajvr.2003.64.835pubmed: 12856767google scholar: lookup
  162. Chan KM, Fu SC. Anti-inflammatory management for tendon injuries - friends or foes?. Sports Med Arthrosc Rehabil Ther Technol (2009) 1:23.
    doi: 10.1186/1758-2555-1-23pmc: PMC2770552pubmed: 19825161google scholar: lookup
  163. Jann HW, Stein LE, Good JK. Strength characteristics and failure modes of locking-loop and three-loop pulley suture patterns in equine tendons. Vet Surg (1990) 19:28–33.
    doi: 10.1111/j.1532-950X.1990.tb01139.xpubmed: 2405581google scholar: lookup
  164. Eliashar E, Schramme MC, Schumacher J, Ikada Y, Smith RK. Use of a bioabsorbable implant for the repair of severed digital flexor tendons in four horses. Vet Rec (2001) 148:506–9.
    doi: 10.1136/vr.148.16.506pubmed: 11345993google scholar: lookup
  165. Smith RK, Korda M, Blunn GW, Goodship AE. Isolation and implantation of autologous equine mesenchymal stem cells from bone marrow into the superficial digital flexor tendon as a potential novel treatment. Equine Vet J (2003) 35:99–102.
    doi: 10.2746/042516403775467388pubmed: 12553472google scholar: lookup
  166. Renzi S, Ricco S, Dotti S, Sesso L, Grolli S, Cornali M. Autologous bone marrow mesenchymal stromal cells for regeneration of injured equine ligaments and tendons: a clinical report. Res Vet Sci (2013) 95:272–7.
    doi: 10.1016/j.rvsc.2013.01.017pubmed: 23419936google scholar: lookup
  167. Filomeno P, Dayan V, Tourino C. Stem cell research and clinical development in tendon repair. Muscles Ligaments Tendons J (2012) 2:204–11.
    pmc: PMC3666527pubmed: 23738298
  168. Costa-Almeida R, Calejo I, Gomes ME. Mesenchymal stem cells empowering tendon regenerative therapies. Int J Mol Sci (2019) 20:3002.
    doi: 10.3390/ijms20123002pmc: PMC6627139pubmed: 31248196google scholar: lookup
  169. Pacini S, Spinabella S, Trombi L, Fazzi R, Galimberti S, Dini F. Suspension of bone marrow-derived undifferentiated mesenchymal stromal cells for repair of superficial digital flexor tendon in race horses. Tissue Eng (2007) 13:2949–55.
    doi: 10.1089/ten.2007.0108pubmed: 17919069google scholar: lookup
  170. Godwin EE, Young NJ, Dudhia J, Beamish IC, Smith RK. Implantation of bone marrow-derived mesenchymal stem cells demonstrates improved outcome in horses with overstrain injury of the superficial digital flexor tendon. Equine Vet J (2012) 44:25–32.
    doi: 10.1111/j.2042-3306.2011.00363.xpubmed: 21615465google scholar: lookup
  171. Smith RK, Werling NJ, Dakin SG, Alam R, Goodship AE, Dudhia J. Beneficial effects of autologous bone marrow-derived mesenchymal stem cells in naturally occurring tendinopathy. PLoS ONE (2013) 8:e75697.
    doi: 10.1371/journal.pone.0075697pmc: PMC3783421pubmed: 24086616google scholar: lookup
  172. Van Loon VJ, Scheffer CJ, Genn HJ, Hoogendoorn AC, Greve JW. Clinical follow-up of horses treated with allogeneic equine mesenchymal stem cells derived from umbilical cord blood for different tendon and ligament disorders. Vet Q (2014) 34:92–7.
    doi: 10.1080/01652176.2014.949390pubmed: 25072527google scholar: lookup
  173. Geburek F, Roggel F, van Schie HTM, Beineke A, Estrada R, Weber K. Effect of single intralesional treatment of surgically induced equine superficial digital flexor tendon core lesions with adipose-derived mesenchymal stromal cells: a controlled experimental trial. Stem Cell Res Ther (2017) 8:129.
    doi: 10.1186/s13287-017-0564-8pmc: PMC5460527pubmed: 28583184google scholar: lookup
  174. Romero A, Barrachina L, Ranera B, Remacha AR, Moreno B, de Blas I. Comparison of autologous bone marrow and adipose tissue derived mesenchymal stem cells, and platelet rich plasma, for treating surgically induced lesions of the equine superficial digital flexor tendon. Vet J (2017) 224:76–84.
    doi: 10.1016/j.tvjl.2017.04.005pubmed: 28697880google scholar: lookup
  175. Harasen G. Diagnosing rupture of the cranial cruciate ligament. Can Vet J (2002) 43:475–6.
    pmc: PMC339306pubmed: 12058576
  176. Chuang C, Ramaker MA, Kaur S, Csomos RA, Kroner KT, Bleedorn JA. Radiographic risk factors for contralateral rupture in dogs with unilateral cranial cruciate ligament rupture. PLoS ONE (2014) 9:e106389.
    doi: 10.1371/journal.pone.0106389pmc: PMC4177807pubmed: 25254499google scholar: lookup
  177. Molsa SH, Hyytiainen HK, Hielm-Bjorkman AK, Laitinen-Vapaavuori OM. Long-term functional outcome after surgical repair of cranial cruciate ligament disease in dogs. BMC Vet Res (2014) 10:266.
    doi: 10.1186/s12917-014-0266-8pmc: PMC4243374pubmed: 25407015google scholar: lookup
  178. Taroni M, Cabon Q, Febre M, Cachon T, Saulnier N, Carozzo C. Evaluation of the effect of a single intra-articular injection of allogeneic neonatal mesenchymal stromal cells compared to oral non-steroidal anti-inflammatory treatment on the postoperative musculoskeletal status and gait of dogs over a 6-month period after tibial plateau leveling osteotomy: a pilot study. Front Vet Sci (2017) 4:83.
    doi: 10.3389/fvets.2017.00083pmc: PMC5463535pubmed: 28642867google scholar: lookup
  179. Linon E, Spreng D, Rytz U, Forterre S. Engraftment of autologous bone marrow cells into the injured cranial cruciate ligament in dogs. Vet J (2014) 202:448–54.
    doi: 10.1016/j.tvjl.2014.08.031pubmed: 25261229google scholar: lookup
  180. Muir P, Hans EC, Racette M, Volstad N, Sample SJ, Heaton C. Autologous bone marrow-derived mesenchymal stem cells modulate molecular markers of inflammation in dogs with cruciate ligament rupture. PLoS ONE (2016) 11:e0159095.
    doi: 10.1371/journal.pone.0159095pmc: PMC5005014pubmed: 27575050google scholar: lookup
  181. Canapp SO Jr, Leasure CS, Cox C, Ibrahim V, Carr BJ. Partial cranial cruciate ligament tears treated with stem cell and platelet-rich plasma combination therapy in 36 dogs: a retrospective study. Front Vet Sci (2016) 3:112.
    doi: 10.3389/fvets.2016.00112pmc: PMC5155010pubmed: 28018908google scholar: lookup
  182. Frisbie DD, Stewart MC. Cell-based therapies for equine joint disease. Vet Clin North Am Equine Pract (2011) 27:335–49.
    doi: 10.1016/j.cveq.2011.06.005pubmed: 21872762google scholar: lookup
  183. Rossdale PD, Hopes R, Digby NJ, offord K. Epidemiological study of wastage among racehorses 1982 and (1983). Vet Rec (1985) 116:66–9.
    doi: 10.1136/vr.116.3.66pubmed: 3976145google scholar: lookup
  184. Walmsley JR, Phillips TJ, Townsend HG. Meniscal tears in horses: an evaluation of clinical signs and arthroscopic treatment of 80 cases. Equine Vet J (2003) 35:402–6.
    doi: 10.2746/042516403776014163pubmed: 12880009google scholar: lookup
  185. Cohen JM, Richardson DW, McKnight AL, Ross MW, Boston RC. Long-term outcome in 44 horses with stifle lameness after arthroscopic exploration and debridement. Vet Surg (2009) 38:543–51.
    doi: 10.1111/j.1532-950X.2009.00524.xpubmed: 19538678google scholar: lookup
  186. Nicpon J, Marycz K, Grzesiak J. Therapeutic effect of adipose-derived mesenchymal stem cell injection in horses suffering from bone spavin. Pol J Vet Sci (2013) 16:753–4.
    doi: 10.2478/pjvs-2013-0107pubmed: 24597313google scholar: lookup
  187. Ferris DJ, Frisbie DD, Kisiday JD, McIlwraith CW, Hague BA, Major MD. Clinical outcome after intra-articular administration of bone marrow derived mesenchymal stem cells in 33 horses with stifle injury. Vet Surg (2014) 43:255–65.
    doi: 10.1111/j.1532-950X.2014.12100.xpubmed: 24433318google scholar: lookup
  188. Marinas-Pardo L, Garcia-Castro J, Rodriguez-Hurtado I, Rodriguez-Garcia MI, Nunez-Naveira L, Hermida-Prieto M. Allogeneic adipose-derived mesenchymal stem cells (horse allo 20) for the treatment of osteoarthritis-associated lameness in horses: characterization, safety, and efficacy of intra-articular treatment. Stem Cells Dev (2018) 27:1147–60.
    doi: 10.1089/scd.2018.0074pubmed: 29978736google scholar: lookup
  189. Mohoric L, Zorko B, Ceh K, Majdic G. Blinded placebo study of bilateral osteoarthritis treatment using adipose derived mesenchymal stem cells. Slovenian Vet Res (2016) 53:167–74.
  190. Black LL, Gaynor J, Gahring D, Adams C, Aron D, Harman S. Effect of adipose-derived mesenchymal stem and regenerative cells on lameness in dogs with chronic osteoarthritis of the coxofemoral joints: a randomized, double-blinded, multicenter, controlled trial. Vet Ther (2007) 8:272–84.
    pubmed: 18183546
  191. Vilar JM, Morales M, Santana A, Spinella G, Rubio M, Cuervo B. Controlled, blinded force platform analysis of the effect of intraarticular injection of autologous adipose-derived mesenchymal stem cells associated to PRGF-Endoret in osteoarthritic dogs. BMC Vet Res (2013) 9:131.
    doi: 10.1186/1746-6148-9-131pmc: PMC3716942pubmed: 23819757google scholar: lookup
  192. Srzentic Drazilov S, Mrkovacki J, Spasovski V, Fazlagic A, Pavlovic S, Nikcevic G. The use of canine mesenchymal stem cells for the autologous treatment of osteoarthritis. Acta Vet Hung (2018) 66:376–89.
    doi: 10.1556/004.2018.034pubmed: 30264620google scholar: lookup
  193. Harman R, Carlson K, Gaynor J, Gustafson S, Dhupa S, Clement K. A prospective, randomized, masked, and placebo-controlled efficacy study of intraarticular allogeneic adipose stem cells for the treatment of osteoarthritis in dogs. Front Vet Sci (2016) 3:81.
    doi: 10.3389/fvets.2016.00081pmc: PMC5025432pubmed: 27695698google scholar: lookup
  194. Shah K, Drury T, Roic I, Hansen P, Malin M, Boyd R. Outcome of allogeneic adult stem cell therapy in dogs suffering from osteoarthritis and other joint defects. Stem Cells Int (2018) 2018:7309201.
    doi: 10.1155/2018/7309201pmc: PMC6046133pubmed: 30050578google scholar: lookup
  195. Li L, Duan X, Fan Z, Chen L, Xing F, Xu Z. Mesenchymal stem cells in combination with hyaluronic acid for articular cartilage defects. Sci Rep (2018) 8:9900.
    doi: 10.1038/s41598-018-27737-ypmc: PMC6028658pubmed: 29967404google scholar: lookup
  196. Guercio A, Di Marco P, Casella S, Cannella V, Russotto L, Purpari G. Canine mesenchymal stem cells from adipose tissue and their application in dogs with chronic osteoarthritis of the humeroradial joints. Cell Biol Int (2012) 36:189–94.
    doi: 10.1042/CBI20110304pubmed: 21936851google scholar: lookup
  197. Cuervo B, Rubio M, Sopena J, Dominguez JM, Vilar J, Morales M. Hip osteoarthritis in dogs: a randomized study using mesenchymal stem cells from adipose tissue and plasma rich in growth factors. Int J Mol Sci (2014) 15:13437–60.
    doi: 10.3390/ijms150813437pmc: PMC4159804pubmed: 25089877google scholar: lookup
  198. Babu NC, Gomes AJ. Systemic manifestations of oral diseases. J Oral Maxillofac Pathol (2011) 15:144–7.
    doi: 10.4103/0973-029X.84477pmc: PMC3329699pubmed: 22529571google scholar: lookup
  199. Petersen PE, Bourgeois D, Ogawa H, Estupinan-Day S, Ndiaye C. The global burden of oral diseases and risks to oral health. Bull World Health Organ (2005) 83:661–9.
    pmc: PMC2626328pubmed: 16211157
  200. Abdelaz P, ElZoghbi A, Shokry M, Ahmed AZ, Rasha H. Reparative dentin formation using stem cell therapy versus calcium hydroxide in direct pulp capping: an animal study. Braz Dent J (2019) 30:542–9.
    doi: 10.1590/0103-6440201902711pubmed: 31800747google scholar: lookup
  201. Iohara K, Utsunomiya S, Kohara S, Nakashima M. Allogeneic transplantation of mobilized dental pulp stem cells with the mismatched dog leukocyte antigen type is safe and efficacious for total pulp regeneration. Stem Cell Res Ther (2018) 9:116.
    doi: 10.1186/s13287-018-0855-8pmc: PMC5921747pubmed: 29703239google scholar: lookup
  202. Colpak HA, Gonen ZB, Ozdamar S, Alkan A, Kutuk N. Vertical ridge augmentation using guided bone regeneration procedure and dental pulp derived mesenchymal stem cells with simultaneous dental implant placement: a histologic study in a sheep model. J Stomatol Oral Maxillofac Surg (2019) 120:216–23.
    doi: 10.1016/j.jormas.2018.12.011pubmed: 30579853google scholar: lookup
  203. Shi H, Zong W, Xu X, Chen J. Improved biphasic calcium phosphate combined with periodontal ligament stem cells may serve as a promising method for periodontal regeneration. Am J Transl Res (2018) 10:4030–41.
    pmc: PMC6325501pubmed: 30662648
  204. Wang P, Wang W, Geng T, Liu Y, Zhu S, Liu Z. EphrinB2 regulates osteogenic differentiation of periodontal ligament stem cells and alveolar bone defect regeneration in beagles. J Tissue Eng (2019) 10:2041731419894361.
    doi: 10.1177/2041731419894361pmc: PMC6918499pubmed: 31897285google scholar: lookup
  205. Xu M, Wei X, Fang J, Xiao L. Combination of SDF-1 and bFGF promotes bone marrow stem cell-mediated periodontal ligament regeneration. Biosci Rep (2019) 39:BSR20190785.
    doi: 10.1042/BSR20190785pmc: PMC6923350pubmed: 31789340google scholar: lookup
  206. Rezaei M, Jamshidi S, Saffarpour A, Ashouri M, Rahbarghazi R, Rokn AR. Transplantation of bone marrow-derived mesenchymal stem cells, platelet-rich plasma, and fibrin glue for periodontal regeneration. Int J Periodont Restor Dent (2019) 39:e32–45.
    doi: 10.11607/prd.3691pubmed: 30543731google scholar: lookup
  207. Venkataiah VS, Handa K, Njuguna MM, Hasegawa T, Maruyama K, Nemoto E. Periodontal regeneration by allogeneic transplantation of adipose tissue derived multi-lineage progenitor stem cells in vivo. Sci Rep (2019) 9:921.
    doi: 10.1038/s41598-018-37528-0pmc: PMC6351614pubmed: 30696909google scholar: lookup
  208. El-Zekrid MH, Mahmoud SH, Ali FA, Helal ME, Grawish ME. Healing capacity of autologous bone marrow-derived mesenchymal stem cells on partially pulpotomized dogs' teeth. J Endod (2019) 45:287–94.
    doi: 10.1016/j.joen.2018.11.013pubmed: 30722983google scholar: lookup
  209. Sanchez-Garces MA, Alvira-Gonzalez J, Sanchez CM, Barbany Cairo JR, Del Pozo MR, Gay-Escoda C. Bone regeneration using adipose-derived stem cells with fibronectin in dehiscence-type defects associated with dental implants: an experimental study in a dog model. Int J Oral Maxillofac Implants (2017) 32:e97–e106.
    doi: 10.11607/jomi.5169pubmed: 28291861google scholar: lookup
  210. Bellei E, Dalla F, Masetti L, Pisoni L, Joechler M. Surgical therapy in chronic feline gingivostomatitis (FCGS). Vet Res Commun (2008) 32(Suppl. 1):S231–4.
    doi: 10.1007/s11259-008-9153-8pubmed: 18685967google scholar: lookup
  211. Hennet PR, Camy GA, McGahie DM, Albouy MV. Comparative efficacy of a recombinant feline interferon omega in refractory cases of calicivirus-positive cats with caudal stomatitis: a randomised, multi-centre, controlled, double-blind study in 39 cats. J Feline Med Surg (2011) 13:577–87.
    doi: 10.1016/j.jfms.2011.05.012pmc: PMC7129178pubmed: 21802033google scholar: lookup
  212. Lommer MJ. Efficacy of cyclosporine for chronic, refractory stomatitis in cats: a randomized, placebo-controlled, double-blinded clinical study. J Vet Dent (2013) 30:8–17.
    doi: 10.1177/089875641303000101pubmed: 23757820google scholar: lookup
  213. Druet I, Hennet P. Relationship between feline calicivirus load, oral lesions, and outcome in feline chronic gingivostomatitis (caudal stomatitis): retrospective study in 104 cats. Front Vet Sci (2017) 4:209.
    doi: 10.3389/fvets.2017.00209pmc: PMC5724031pubmed: 29270412google scholar: lookup
  214. Winer JN, Arzi B, Verstraete FJ. Therapeutic management of feline chronic gingivostomatitis: a systematic review of the literature. Front Vet Sci (2016) 3:54.
    doi: 10.3389/fvets.2016.00054pmc: PMC4947586pubmed: 27486584google scholar: lookup
  215. Arzi B, Mills-Ko E, Verstraete FJ, Kol A, Walker NJ, Badgley MR. Therapeutic efficacy of fresh, autologous mesenchymal stem cells for severe refractory gingivostomatitis in cats. Stem Cells Transl Med (2016) 5:75–86.
    doi: 10.5966/sctm.2015-0127pmc: PMC4704876pubmed: 26582907google scholar: lookup
  216. Arzi B, Clark KC, Sundaram A, Spriet M, Verstraete FJM, Walker NJ. Therapeutic efficacy of fresh, allogeneic mesenchymal stem cells for severe refractory feline chronic gingivostomatitis. Stem Cells Transl Med (2017) 6:1710–22.
    doi: 10.1002/sctm.17-0035pmc: PMC5689767pubmed: 28618186google scholar: lookup
  217. Arzi B, Peralta S, Fiani N, Vapniarsky N, Taechangam N, Delatorre U. A multicenter experience using adipose-derived mesenchymal stem cell therapy for cats with chronic, non-responsive gingivostomatitis. Stem Cell Res Ther (2020) 11:115.
    doi: 10.1186/s13287-020-01623-9pmc: PMC7071622pubmed: 32169089google scholar: lookup
  218. Cerquetella M, Spaterna A, Laus F, Tesei B, Rossi G, Antonelli E. Inflammatory bowel disease in the dog: differences and similarities with humans. World J Gastroenterol (2010) 16:1050–6.
    doi: 10.3748/wjg.v16.i9.1050pmc: PMC2835779pubmed: 20205273google scholar: lookup
  219. Perez-Merino EM, Uson-Casaus JM, Duque-Carrasco J, Zaragoza-Bayle C, Marinas-Pardo L, Hermida-Prieto M. Safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells for treatment of dogs with inflammatory bowel disease: Endoscopic and histological outcomes. Vet J (2015) 206:391–7.
    doi: 10.1016/j.tvjl.2015.07.023pubmed: 26526521google scholar: lookup
  220. Webb TL, Webb CB. Stem cell therapy in cats with chronic enteropathy: a proof-of-concept study. J Feline Med Surg (2015) 17:901–8.
    doi: 10.1177/1098612X14561105pmc: PMC11112192pubmed: 25480816google scholar: lookup
  221. Matsuda T, Takami T, Sasaki R, Nishimura T, Aibe Y, Paredes BD. A canine liver fibrosis model to develop a therapy for liver cirrhosis using cultured bone marrow-derived cells. Hepatol Commun (2017) 1:691–703.
    doi: 10.1002/hep4.1071pmc: PMC5721436pubmed: 29404486google scholar: lookup
  222. Gardin C, Ferroni L, Bellin G, Rubini G, Barosio S, Zavan B. Therapeutic potential of autologous adipose-derived stem cells for the treatment of liver disease. Int J Mol Sci (2018) 19:4064.
    doi: 10.3390/ijms19124064pmc: PMC6321531pubmed: 30558283google scholar: lookup
  223. Nam A, Han SM, Go DM, Kim DY, Seo KW, Youn HY. Long-term management with adipose tissue-derived mesenchymal stem cells and conventional treatment in a dog with hepatocutaneous syndrome. J Vet Intern Med (2017) 31:1514–9.
    doi: 10.1111/jvim.14798pmc: PMC5598886pubmed: 28782844google scholar: lookup
  224. Adin CA, Gregory CR, Kyles AE, Cowgill L. Diagnostic predictors of complications and survival after renal transplantation in cats. Vet Surg (2001) 30:515–21.
    doi: 10.1053/jvet.2001.28418pubmed: 11704946google scholar: lookup
  225. Quimby JM, Webb TL, Gibbons DS, Dow SW. Evaluation of intrarenal mesenchymal stem cell injection for treatment of chronic kidney disease in cats: a pilot study. J Feline Med Surg (2011) 13:418–26.
    doi: 10.1016/j.jfms.2011.01.005pmc: PMC10832716pubmed: 21334237google scholar: lookup
  226. Vidane AS, Pinheiro AO, Casals JB, Passarelli D, Hage M, Bueno RS. Transplantation of amniotic membrane-derived multipotent cells ameliorates and delays the progression of chronic kidney disease in cats. Reprod Domest Anim (2017) 52(Suppl. 2):316–26.
    doi: 10.1111/rda.12846pubmed: 27774657google scholar: lookup
  227. Quimby JM, Webb TL, Habenicht LM, Dow SW. Safety and efficacy of intravenous infusion of allogeneic cryopreserved mesenchymal stem cells for treatment of chronic kidney disease in cats: results of three sequential pilot studies. Stem Cell Res Ther (2013) 4:48.
    doi: 10.1186/scrt198pmc: PMC3707049pubmed: 23632128google scholar: lookup
  228. Quimby JM, Webb TL, Randall E, Marolf A, Valdes-Martinez A, Dow SW. Assessment of intravenous adipose-derived allogeneic mesenchymal stem cells for the treatment of feline chronic kidney disease: a randomized, placebo-controlled clinical trial in eight cats. J Feline Med Surg (2016) 18:165–71.
    doi: 10.1177/1098612X15576980pmc: PMC11149004pubmed: 25784460google scholar: lookup
  229. Wernly B, Mirna M, Rezar R, Prodinger C, Jung C, Podesser BK. Regenerative cardiovascular therapies: stem cells and beyond. Int J Mol Sci (2019) 20:1420.
    doi: 10.3390/ijms20061420pmc: PMC6470623pubmed: 30901815google scholar: lookup
  230. Hoffman AM, Dow SW. Concise review: stem cell trials using companion animal disease models. Stem Cells (2016) 34:1709–29.
    doi: 10.1002/stem.2377pubmed: 27066769google scholar: lookup
  231. Pogue B, Estrada AH, Sosa-Samper I, Maisenbacher HW, Lamb KE, Mincey BD. Stem-cell therapy for dilated cardiomyopathy: a pilot study evaluating retrograde coronary venous delivery. J Small Anim Pract (2013) 54:361–6.
    doi: 10.1111/jsap.12098pubmed: 23731226google scholar: lookup
  232. Hensley MT, Tang J, Woodruff K, Defrancesco T, Tou S, Williams CM. Intracoronary allogeneic cardiosphere-derived stem cells are safe for use in dogs with dilated cardiomyopathy. J Cell Mol Med (2017) 21:1503–12.
    doi: 10.1111/jcmm.13077pmc: PMC5543505pubmed: 28296006google scholar: lookup
  233. Fox PR. Pathology of myxomatous mitral valve disease in the dog. J Vet Cardiol (2012) 14:103–26.
    doi: 10.1016/j.jvc.2012.02.001pubmed: 22386587google scholar: lookup
  234. Petchdee S, Sompeewong S. Intravenous administration of puppy deciduous teeth stem cells in degenerative valve disease. Vet World (2016) 9:1429–34.
    doi: 10.14202/vetworld.2016.1429-1434pmc: PMC5234058pubmed: 28096616google scholar: lookup
  235. Barussi FC, Bastos FZ, Leite LM, Fragoso FY, Senegaglia AC, Brofman PR. Intratracheal therapy with autologous bone marrow-derived mononuclear cells reduces airway inflammation in horses with recurrent airway obstruction. Respir Physiol Neurobiol (2016) 232:35–42.
    doi: 10.1016/j.resp.2016.07.002pubmed: 27396936google scholar: lookup
  236. Hao Y, Ran Y, Lu B, Li J, Zhang J, Feng C. Therapeutic effects of human umbilical cord-derived mesenchymal stem cells on canine radiation-induced lung injury. Int J Radiat Oncol Biol Phys (2018) 102:407–16.
    doi: 10.1016/j.ijrobp.2018.05.068pubmed: 30191872google scholar: lookup
  237. Trzil JE, Masseau I, Webb TL, Chang CH, Dodam JR, Liu H. Intravenous adipose-derived mesenchymal stem cell therapy for the treatment of feline asthma: a pilot study. J Feline Med Surg (2016) 18:981–90.
    doi: 10.1177/1098612X15604351pmc: PMC11112236pubmed: 26384398google scholar: lookup
  238. Besalti O, Aktas Z, Can P, Akpinar E, Elcin AE, Elcin YM. The use of autologous neurogenically-induced bone marrow-derived mesenchymal stem cells for the treatment of paraplegic dogs without nociception due to spinal trauma. J Vet Med Sci (2016) 78:1465–73.
    doi: 10.1292/jvms.15-0571pmc: PMC5059374pubmed: 27301583google scholar: lookup
  239. Penha EM, Meira CS, Guimaraes ET, Mendonca MV, Gravely FA, Pinheiro CM. Use of autologous mesenchymal stem cells derived from bone marrow for the treatment of naturally injured spinal cord in dogs. Stem Cells Int (2014) 2014:437521.
    doi: 10.1155/2014/437521pmc: PMC3956412pubmed: 24723956google scholar: lookup
  240. Bhat IA, T BS, Somal A, Pandey S, Bharti MK, Panda BSK. An allogenic therapeutic strategy for canine spinal cord injury using mesenchymal stem cells. J Cell Physiol (2019) 234:2705–18.
    doi: 10.1002/jcp.27086pubmed: 30132873google scholar: lookup
  241. Bach FS, Rebelatto CLK, Fracaro L, Senegaglia AC, Fragoso FYI, Daga DR. Comparison of the efficacy of surgical decompression alone and combined with canine adipose tissue-derived stem cell transplantation in dogs with acute thoracolumbar disk disease and spinal cord injury. Front Vet Sci (2019) 6:383.
    doi: 10.3389/fvets.2019.00383pmc: PMC6857468pubmed: 31781580google scholar: lookup
  242. Steffen F, Smolders LA, Roentgen AM, Bertolo A, Stoyanov J. Bone marrow-derived mesenchymal stem cells as autologous therapy in dogs with naturally occurring intervertebral disc disease: feasibility, safety, and preliminary results. Tissue Eng Part C Methods (2017) 23:643–51.
    doi: 10.1089/ten.tec.2017.0033pubmed: 28471303google scholar: lookup
  243. Wu GH, Shi HJ, Che MT, Huang MY, Wei QS, Feng B. Recovery of paralyzed limb motor function in canine with complete spinal cord injury following implantation of MSC-derived neural network tissue. Biomaterials (2018) 181:15–34.
    doi: 10.1016/j.biomaterials.2018.07.010pubmed: 30071379google scholar: lookup
  244. Ojeh N, Pastar I, Tomic-Canic M, Stojadinovic O. Stem cells in skin regeneration, wound healing, and their clinical applications. Int J Mol Sci (2015) 16:25476–501.
    doi: 10.3390/ijms161025476pmc: PMC4632811pubmed: 26512657google scholar: lookup
  245. Pratheesh MD, Dubey PK, Gade NE, Nath A, Sivanarayanan TB, Madhu DN. Comparative study on characterization and wound healing potential of goat (Capra hircus) mesenchymal stem cells derived from fetal origin amniotic fluid and adult bone marrow. Res Vet Sci (2017) 112:81–8.
    doi: 10.1016/j.rvsc.2016.12.009pubmed: 28135618google scholar: lookup
  246. Martinello T, Gomiero C, Perazzi A, Iacopetti I, Gemignani F, DeBenedictis GM. Allogeneic mesenchymal stem cells improve the wound healing process of sheep skin. BMC Vet Res (2018) 14:202.
    doi: 10.1186/s12917-018-1527-8pmc: PMC6019727pubmed: 29940954google scholar: lookup
  247. Textor JA, Clark KC, Walker NJ, Aristizobal FA, Kol A, LeJeune SS. Allogeneic stem cells alter gene expression and improve healing of distal limb wounds in horses. Stem Cells Transl Med (2018) 7:98–108.
    doi: 10.1002/sctm.17-0071pmc: PMC5746157pubmed: 29063737google scholar: lookup
  248. Johnson V, Webb T, Norman A, Coy J, Kurihara J, Regan D. Activated mesenchymal stem cells interact with antibiotics and host innate immune responses to control chronic bacterial infections. Sci Rep (2017) 7:9575.
    doi: 10.1038/s41598-017-08311-4pmc: PMC5575141pubmed: 28851894google scholar: lookup
  249. Lanci A, Merlo B, Mariella J, Castagnetti C, Iacono E. Heterologous Wharton's Jelly derived mesenchymal stem cells application on a large chronic skin wound in a 6-month-old filly. Front Vet Sci (2019) 6:9.
    doi: 10.3389/fvets.2019.00009pmc: PMC6363668pubmed: 30761313google scholar: lookup
  250. Hall MN, Rosenkrantz WS, Hong JH, Griffin CE, Mendelsohn CM. Evaluation of the potential use of adipose-derived mesenchymal stromal cells in the treatment of canine atopic dermatitis: a pilot study. Vet Ther (2010) 11:E1–14.
    pubmed: 20957613
  251. Villatoro AJ, Hermida-Prieto M, Fernandez V, Farinas F, Alcoholado C, Rodriguez-Garcia MI. Allogeneic adipose-derived mesenchymal stem cell therapy in dogs with refractory atopic dermatitis: clinical efficacy and safety. Vet Rec (2018) 183:654.
    doi: 10.1136/vr.104867pubmed: 30158120google scholar: lookup
  252. Davis AB, Schnabel LV, Gilger BC. Subconjunctival bone marrow-derived mesenchymal stem cell therapy as a novel treatment alternative for equine immune-mediated keratitis: a case series. Vet Ophthalmol (2019) 22:674–82.
    doi: 10.1111/vop.12641pubmed: 30715781google scholar: lookup
  253. Saldinger LK, Nelson SG, Bellone RR, Lassaline M, Mack M, Walker NJ. Horses with equine recurrent uveitis have an activated CD4+ T-cell phenotype that can be modulated by mesenchymal stem cells in vitro. Vet Ophthalmol (2020) 23:160–70.
    doi: 10.1111/vop.12704pmc: PMC6980227pubmed: 31441218google scholar: lookup
  254. Villatoro AJ, Claros S, Fernandez V, Alcoholado C, Farinas F, Moreno A. Safety and efficacy of the mesenchymal stem cell in feline eosinophilic keratitis treatment. BMC Vet Res (2018) 14:116.
    doi: 10.1186/s12917-018-1413-4pmc: PMC5870249pubmed: 29587744google scholar: lookup
  255. Villatoro AJ, Fernandez V, Claros S, Rico-Llanos GA, Becerra J, Andrades JA. Use of adipose-derived mesenchymal stem cells in keratoconjunctivitis sicca in a canine model. Biomed Res Int (2015) 2015:527926.
    doi: 10.1155/2015/527926pmc: PMC4352730pubmed: 25802852google scholar: lookup
  256. Sgrignoli MR, Silva DA, Nascimento FF, Sgrignoli DAM, Nai GA, da Silva MG. Reduction in the inflammatory markers CD4, IL-1, IL-6 and TNFα in dogs with keratoconjunctivitis sicca treated topically with mesenchymal stem cells. Stem Cell Res (2019) 39:101525.
    doi: 10.1016/j.scr.2019.101525pubmed: 31430719google scholar: lookup
  257. Grady ST, Watts AE, Thompson JA, Penedo MCT, Konganti K, Hinrichs K. Effect of intra-ovarian injection of mesenchymal stem cells in aged mares. J Assist Reprod Genet (2019) 36:543–56.
    doi: 10.1007/s10815-018-1371-6pmc: PMC6439078pubmed: 30470961google scholar: lookup
  258. Papa PM, Guasti PN, De Vita B, Nakazato NG, Maia L, Freitas Dell'Aqua CP. Clinical safety of intratesticular transplantation of allogeneic bone marrow multipotent stromal cells in stallions. Reprod Domest Anim (2020) 55:429–37.
    doi: 10.1111/rda.13624pubmed: 31916315google scholar: lookup
  259. Qamar AY, Fang X, Kim MJ, Cho J. Improved post-thaw quality of canine semen after treatment with exosomes from conditioned medium of adipose-derived mesenchymal stem cells. Animals (2019) 9:865.
    doi: 10.3390/ani9110865pmc: PMC6912283pubmed: 31731505google scholar: lookup
  260. Lara E, Rivera N, Cabezas J, Navarrete F, Saravia F, Rodriguez-Alvarez L. Endometrial stem cells in farm animals: potential role in uterine physiology and pathology. Bioengineering (2018) 5:75.
    doi: 10.3390/bioengineering5030075pmc: PMC6163755pubmed: 30231577google scholar: lookup
  261. Miernik K, Karasinski J. Porcine uterus contains a population of mesenchymal stem cells. Reproduction (2012) 143:203–9.
    doi: 10.1530/REP-11-0202pubmed: 22065860google scholar: lookup
  262. Cabezas J, Lara E, Pacha P, Rojas D, Veraguas D, Saravia F. The endometrium of cycling cows contains populations of putative mesenchymal progenitor cells. Reprod Domest Anim (2014) 49:550–9.
    doi: 10.1111/rda.12309pubmed: 24754629google scholar: lookup
  263. Letouzey V, Tan KS, Deane JA, Ulrich D, Gurung S, Ong YR. Isolation and characterisation of mesenchymal stem/stromal cells in the ovine endometrium. PLoS ONE (2015) 10:e0127531.
    doi: 10.1371/journal.pone.0127531pmc: PMC4436363pubmed: 25992577google scholar: lookup
  264. Tamadon A, Mehrabani D, Zarezadeh Y, Rahmanifar F, Dianatpour M, Zare S. Caprine endometrial mesenchymal stromal stem cell: multilineage potential, characterization, and growth kinetics in breeding and anestrous stages. Vet Med Int (2017) 2017:5052801.
    doi: 10.1155/2017/5052801pmc: PMC5357535pubmed: 28357151google scholar: lookup
  265. Cabezas J, Rojas D, Navarrete F, Ortiz R, Rivera G, Saravia F. Equine mesenchymal stem cells derived from endometrial or adipose tissue share significant biological properties, but have distinctive pattern of surface markers and migration. Theriogenology (2018) 106:93–102.
    doi: 10.1016/j.theriogenology.2017.09.035pubmed: 29049924google scholar: lookup
  266. Mambelli LI, Winter GH, Kerkis A, Malschitzky E, Mattos RC, Kerkis I. A novel strategy of mesenchymal stem cells delivery in the uterus of mares with endometrosis. Theriogenology (2013) 79:744–50.
    doi: 10.1016/j.theriogenology.2012.11.030pubmed: 23270861google scholar: lookup
  267. Cahuascanco B, Bahamonde J, Huaman O, Jervis M, Cortez J, Palomino J. Bovine fetal mesenchymal stem cells exert antiproliferative effect against mastitis causing pathogen Staphylococcus aureus. Vet Res (2019) 50:25.
    doi: 10.1186/s13567-019-0643-1pmc: PMC6460550pubmed: 30975214google scholar: lookup
  268. Costa CRM, Feitosa MLT, Rocha AR, Bezerra DO, Leite YKC, Argolo Neto NM. Adipose stem cells in reparative goat mastitis mammary gland. PLoS ONE (2019) 14:e0223751.
    doi: 10.1371/journal.pone.0223751pmc: PMC6804991pubmed: 31639137google scholar: lookup
  269. EMA nQuestions and Answers on Allogeneic Stem Cell-Based Products for Veterinary Use: Specific Questions on Extraneous Agents. (2019). Available online at: https://www.ema.europa.eu/en/documents/scientific-guideline/questions-answers-allogeneic-stem-cell-based-products-veterinary-use-specific-questions-sterility_en.pdf (accessed February 15, 2020).
  270. FDA nVeterinary Regenerative Medicine & Animal Cell-Based Products. (2020). Available online at: https://www.fda.gov/animal-veterinary/development-approval-process/veterinary-regenerative-medicine-animal-cell-based-products~ (accessed February 15, 2020).
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.